The availability of weight loss drugs on the NHS doesn’t mean people can give up healthy lifestyles, Health Secretary Wes ...
The co-founder of Regeneron has warned that blockbuster weight-loss drugs could cause “more harm than good ... and Wegovy maker Novo Nordisk and Eli Lilly, the company behind Mounjaro and Zepbound.
A portfolio holding that checks all these boxes is analog chip maker Texas Instruments (TXN). The company invests to build out its own manufacturing capacity, which helps make it a low-cost supplier.
NHS study reveals we are a stone heavier than 30 years ago as experts warn obesity is ‘one of the greatest public health ...
The wife of the country singer took a small dose of tirzepatide, a weight loss drug commonly used to treat diabetes ...
Wes Streeting has warned the availability of such treatments on the NHS should not result in obese people believing that “it ...